31.74
+0.11
+(0.36%)
At close: January 17 at 5:35:36 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 13 | 13 |
| Avg. Estimate | 13.35B | 13.04B | 54.92B | 56.57B |
| Low Estimate | 13.21B | 12.76B | 54.47B | 55.64B |
| High Estimate | 13.49B | 13.25B | 55.15B | 57.57B |
| Year Ago Sales | 13.19B | 12.8B | 53.56B | 54.92B |
| Sales Growth (year/est) | 1.25% | 1.86% | 2.54% | 3.01% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 7HP.DE | -- | -- | -- | -- |
| S&P 500 | 9.38% | 11.28% | 14.02% | 13.55% |
Upgrades & Downgrades
| Maintains | Bernstein: Market Perform to Market Perform | 1/3/2025 |
| Downgrade | HSBC: Buy to Hold | 11/29/2024 |
| Maintains | TD Cowen: Hold to Hold | 11/27/2024 |
| Maintains | Citigroup: Neutral to Neutral | 11/27/2024 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 11/27/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 11/20/2024 |